Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance

Summary

Primary Objective: To demonstrate the non-inferiority, in terms of clinical and parasitological efficacy on Day 14, of administration of Arsucam® as a single daily intake versus two daily intakes. Secondary Objective: To compare the clinical safety of the two treatment regimens.

Timeline

Start

2005-06

Primary completion

—

Completion

—

Drugs

Indications